A groundbreaking five-year study reveals that a low-carbohydrate diet, paired with continuous remote care, helps people with type 2 diabetes achieve long-lasting remission and dramatically reduce their medication use. Study: 5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study. Image Credit: Stokkete / Shutterstock In a recent study published in the journal Diabetes Research and Clinical Practice , researchers evaluated a telemedicine intervention aiming to help people with type 2 diabetes (T2D) follow a very low-carbohydrate diet to achieve nutritional ketosis.
Their findings indicate that the intervention showed high retention levels, resulting in significant health improvements over five years, including weight loss, increased HDL cholesterol by 17.4%, decreased triglycerides by 18.4%, reduced inflammation markers such as a 43.
6% drop in high-sensitivity C-reactive protein (hs-CRP), improved cardiometabolic health, and diabetes remission. Background Medication reduction success: Over 46% of diabetes medication changes in the study were eliminations, and nearly 60% when excluding metformin, showing a significant reduction in the need for glucose-lowering drugs. T2D has traditionally been seen as a progressive, chronic disease, but new evidence suggests that therapies can reverse it, lowering glycated hemoglobin (HbA1c) levels and reducing the need for glucos.